The medication initially known as VX-548 blocks sodium channels in nerves, blocking pain signals before they reach the brain.
3 months ago

Researchers have developed a novel, non-addictive, non-toxic painkiller that offers the hope of pain relief while also addressing the opioid crisis.
6 months ago

A new study led by Washington University School of Medicine in St. Louis has identified a potential route to pain relief that neither triggers addiction nor...
1 month ago

Vertex Pharmaceuticals' experimental drug reduced acute, post-surgical pain without the risk of addiction, a major milestone in the...
10 months ago

Non-addictive pain medications offer hope to alleviate the disease burden associated with pain. Acute pain is unwelcome and burdensome.
6 months ago

An estimated one in five Americans live with chronic pain and current treatment options leave much to be desired. Feixiong Cheng, Ph.D.,...
1 month ago

This Q&A with Dr Hernan A Bazan, CEO and Co-founder of South Rampart Pharma, Inc, discusses the potential merits of novel non-opioid...
5 months ago

Virpax Pharmaceuticals advances development of NES100, a breakthrough nasal spray using nanotechnology to deliver pain relief without...
2 weeks ago

While there's a need for novel non-opioid drugs for pain, they face clinical development and reimbursement challenges.
8 months ago

Patients suffering from pain have limited options when it comes to medication. For decades, the only two choices have been over-the-counter...
7 months ago